Therapeutics based upon using the adaptive immune system to fight against tumours have become the most promising in the field. Increasing evidence has shown that multiform cell death-mediated events play vital roles in regulating adaptive immune responses within tumours, thus providing potential antitumour therapeutic targets. However, Albert et al. neglected the fact that dying tumour cells may also regulate adaptive immune responses in another way: namely, by prompting T cell exhaustion. Previous studies have shown that dying tumour cells can release tumour antigens, which can serve as damage-associated molecular patterns (DAMPs), into the tumour microenvironment 2, 3 . These tumour antigens persistently stimulate adaptive immune cells such as CD8 + and CD4 + T cells and induce the latter to acquire a dys functional state called T cell exhaustion 4 . Unlike tolerance to a self-antigen, T cell exhaustion is a dysfunctional state characterized by reduced cytokine production and compromised cellkilling ability 5 . Mounting evidence has shown that T cell exhaustion contributes significantly to tumorigenesis and may induce failure of antitumour therapeutics 6 . Therefore, besides actively regulating antitumour adaptive immune responses, dying tumour cells may also compromise antitumour immunity by inducing T cell exhaustion.
The authors highlighted the importance of type I interferons (IFNs), which can be released by dying cells as a type of 'inducible DAMP (iDAMP)' in treatment-associated immunogenic cell death. However, several studies have suggested that type I IFN signalling has contradictory roles in adaptive immune response. For example, Wang et al. showed that the up regulation of IFNβ expression in dendritic cells promoted antigen presentation but compromised T cell priming 7 . Another study showed that elevated levels of type I IFNs during type 1 diabetes triggered lymphocyte exhaustion and disabled lymphocyte-mediated immune responses 8 . In a tumour-bearing mouse model, IFNα augmented programmed cell death 1 (PD1) expression on antigenspecific CD8 + T cells and thus significantly inhibited T cell-mediated immunity 9 . In a chronic infection model, blocking type I IFN signalling decreased T cell exhaustion and viral replication 10 . Therefore, type I IFNs might also impair adaptive immunity by inducing T cell exhaustion in tumours.
In summary, besides the effects of dying cells on adaptive immunity that are detailed by Albert et al., dying cells might have another effect on adaptive immunity: that is, inducing T cell exhaustion.
